Studies have shown that IMD could reduce the expression of major inflammatory factors in sepsis by regulating the NLRP3/Caspase-1/IL-1β pathway, thereby exerting a protective effect against sepsis-induced cardiac dysfunction (Johnson et al., 2018). The gene discussed is IL1B; the disease is Sepsis.